Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Exclusive: Glaxo’s Witty On Why He Shuns Megadeals
Exclusive: Glaxo’s Witty On Why He Shuns Megadeals
Exclusive: Glaxo’s Witty On Why He Shuns Megadeals
Submitted by
admin
on December 31, 2010 - 9:55am
Source:
Forbes
News Tags:
GSK
Andrew Witty
M&A
Pharma CEOs
Headline:
Exclusive: Glaxo’s Witty On Why He Shuns Megadeals
Do Not Allow Advertisers to Use My Personal information
